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Cambridge NeuroScience, Incorporated neuroblasts ( Figure 1B ) . One Kendall Square NT-3 also promotes cell cycle withdrawal in cortical Cambridge, Massachusetts 02139 neuroepithelial precursors (Ghosh and Greenberg, † Amgen Institute 1995). However, NT-3 is not unique in this action; ciliary 620 University Avenue neurotrophic factor (CNTF) has a similar effect on symToronto, Ontario pathetic neuroblasts as well (Ernsberger et al., 1989b; Canada Verdi and Anderson, 1994) . Indeed, antimitotic agents such as aphidicolin and mitomycin C induce TrkA even more efficiently than high doses of NT-3 and CNTF, Summary suggesting that expression of this neurotrophin receptor is primarily a consequence of mitotic arrest ( Figure 1B ) Neurotrophin 3 (NT-3) can support the survival of some . embryonic sympathetic neuroblasts before they beOnce TrkA is expressed, NGF in turn is able to upcome nerve growth factor dependent. We show that regulate expression of the low affinity NGF receptor p75 NT-3 is produced in vivo by nonneuronal cells neigh-( Figure 1B ) (Wyatt and Davies, 1993 ; Verdi and Anderboring embryonic sympathetic ganglia. NT-3 mRNA is son, 1994) . A likely consequence of such increased p75 produced by these nonneuronal cells in vitro and is expression is an enhanced sensitivity to NGF (Davies et up-regulated by platelet-derived growth factor, ciliary Barker and Shooter, 1994;  Hantzopoulos et neurotrophic factor, and glial growth factor 2 (a neu al., 1994; Verdi et al., 1994a) . NGF can regulin). Nonneuronal cell-conditioned medium proalso down-regulate TrkC expression in the neuroblasts motes survival and induces TrkA expression in isolated ( Figure 1B ) (Verdi et al., 1994b) and in this way may sympathetic neuroblasts, and this activity is blocked contribute to the switch from NT-3 dependence to NGF by anti-NT-3 antibody. Neuroblasts also enhance NT-3 dependence. These data illustrate the way in which a production by nonneuronal cells. Neuroblasts syntherelay or cascade of neurotrophins and neuropoietic cysize several forms of neuregulin, and antibodies to tokines can regulate sequential steps in the survival, neuregulin attenuate the effect of the neuroblasts on early differentiation, and cell cycle arrest of primary symthe nonneuronal cells. These data suggest a reciprocal pathetic neuroblasts in vitro. Similar conclusions have cell-cell interaction, in which neuroblast-derived neubeen drawn from studies of immortalized sympathoadregulins promote NT-3 production by neighboring nonrenal progenitors (Ip et al., 1994) . neuronal cells, which in turn promotes neuroblast surTargeted inactivation of the NT-3 gene by homologous vival and further differentiation.
recombination in mice leads to a 50% reduction in neuronal number in superior cervical sympathetic ganglia (Ernfors et al., 1994; Fariñ as et al., 1994) . By contrast, Introduction no such effect on sympathetic development was observed in mice bearing a null mutation in the CNTF gene Growing evidence indicates that neurotrophins act not (Masu et al., 1993) or in the leukemia inhibitory factor only as target-derived neuronal survival factors, but also (LIF) gene (Rao et al., 1993) , which encodes a cytokine can regulate mitotic activity and promote differentiation that interacts with a related receptor (Davis et al., 1993) . of neuronal progenitor cells, their survival, or both, in
In addition, CNTF expression is low or undetectable in both the PNS (Sieber-Blum, 1991; Kalcheim et al., 1992;  early embryogenesis (Stö ckli et al., 1989 (Stö ckli et al., , 1991 . These Wright et al., 1992) and CNS (Cattaneo and McKay, 1990;  data provide evidence that NT-3 is important for the Collazo et al., 1992; Segal et al., 1992 ; Ghosh and development of at least some sympathetic neurons in Greenberg, 1995; Vicario-Abejó n et al., 1995) . For examvivo, although they do not exclude a role for a CNTFple, embryonic rat sympathetic neuroblasts can be suprelated molecule (Leung et al., 1992; Ip et al., 1993) . ported by neurotrophin 3 (NT-3) before they become
The demonstration that NT-3 is essential in sympathetic nerve growth factor (NGF) dependent  neurogenesis in vivo means that it is important to define its source and the regulation of its production. Previous work indicated that NT-3 mRNA can be detected in form- ing sympathetic ganglia at E14.5 (Schecterson and Figure 1 . Schematics Showing the Switch in Neurotrophin Responsiveness by Embryonic Rat Sympathetic Neuroblasts, and the Regulatory Circuits Underlying the Switch Figure 2 . Expression of NT-3 in Sympathetic Ganglionic Nonneu-(A) The switch in neurotrophin responsiveness by embryonic rat ronal Cells In Vivo sympathetic neuroblasts DiCicco-Bloom et al., Transverse sections through the thoracic region of E13.5 mouse 1993).
embryos containing two copies of the lacZ gene inserted into the (B) The regulatory circuits underlying the switch.
NT-3 locus by homologous recombination. In (A), the sections are The induction of TrkA expression in neuroblasts exposed to counterstained with antibody to peripherin; arrows indicate the symor CNTF appears to be primarily a consequence of mitotic arrest pathetic ganglia. In (B), the sections are counterstained with anti- . In vitro, exposure of TrkA-expressing body to p75, which reveals nonneuronal cells adjacent to the sympaneuroblasts to NGF results in both an induction of p75 expression thetic ganglion. Ao, dorsal aorta; sg, sympathetic ganglion. (Wyatt and Davies, 1993; Verdi and Anderson, 1994) and a downregulation of TrkC expression (Verdi et al., 1994b). neuroblasts by surrounding nn cells and that its production in these cells may in turn be regulated by neuroblastderived signals including neuregulins. In this way, a reBothwell, 1992); however, these studies did not identify the cell type(s) that produce NT-3. ciprocal cell-cell interaction mediated by neurotrophins and neuregulins may control the early survival and develHere we demonstrate that NT-3 is produced by nonneuronal (nn) cells immediately surrounding sympaopment of sympathetic neuroblasts. thetic ganglia, among which are glial progenitors. In vitro, NT-3 mRNA expression in these nn cells can be Results strongly up-regulated by glial growth factor 2 (GGF2, a neuregulin), platelet-derived growth factor (PDGF), and NT-3 Is Expressed in nn Cells Surrounding Sympathetic Ganglia CNTF. The induction of NT-3 mRNA in these nn cells is paralleled by an increased secretion of survival-promotTo determine the site of NT-3 expression relative to sympathetic ganglia in vivo, we examined sections of ing and TrkA-inducing activity for sympathetic neuroblasts; both such biological activities are inhibited by fetal mice harboring a lacZ gene inserted into the NT-3 locus by homologous recombination (Fariñ as et al., blocking anti-NT-3 antibodies. Addition of isolated sympathetic neuroblasts to nn cells also up-regulates NT-3 1994) . The expression pattern of ␤-galactosidase in these mice reflects the expression of endogenous NT-3 mRNA and enhances secretion of neuroblast survivalpromoting activity, which is blocked by anti-NT-3 anti-(I. F., unpublished data). Strikingly, ␤-galactosidasepositive cells in these mice surrounded but excluded body. Freshly isolated sympathetic neuroblasts contain various forms of neuregulin mRNA. The effect of the sympathetic ganglia primordia as revealed by counterstaining with antibody to peripherin (Figure 2A , arrows). neuroblasts on nonneuronal cells is attenuated by anti-GGF/neuregulin antibodies. Taken together, these data
The distribution of the ␤-galactosidase positive cells at E13.5 overlapped that of cells expressing p75 LNGFR , a suggest that NT-3 is provided to embryonic sympathetic ϩ Ganglionic Nonneuronal Cells Rat E14.5 thoracic sympathetic ganglia were dissociated and sorted by use of anti-p75 monoclonal antibody. The isolated p75 ϩ cells were plated overnight, fixed, and stained with rabbit anti-NT-3 antibody (see Experimental Procedures) at a 1:1000 dilution (A and B) or preimmune serum at the same dilution as a control (C and D). (A) and (C) are phase contrast micrographs of the bright-field images in (B) and (D), respectively. marker of peripheral glia and their neural crest progeninonneuronal cells (see Experimental Procedures). Because of the larger cell numbers obtained, it was more tors (Stemple and Anderson, 1992) (Figure 2B , arrow). p75 ϩ nn cells isolated from rat E14.5 sympathetic ganconvenient to work with B2 Ϫ cells than p75 ϩ cells as a source of immunoisolated nn cells. These nonneuronal glia by preparative flow cytometry were labeled by an antibody to NT-3 (see Experimental Procedures; Figure  cells were cultured in an insulin-free, serum-free defined medium in the presence of various growth factors, in-3A and 3B). The expression of NT-3 mRNA in these cells was independently confirmed by reverse transcriptioncluding epidermal growth factor (EGF), insulin-like growth factor (IGF)-1 and IGF-2, fibroblast growth factor polymerase chain reaction (RT-PCR) analysis, which also indicated that NT-3 mRNA was undetectable in (FGF), NGF, brain-derived neurotrophic factor (BDNF), retinoic acid, and members of the transforming growth neuroblasts isolated with monoclonal antibody B2 (see below; data not shown). Thus, both the antibody staining factor-␤ (TGF␤) superfamily. Of these factors, CNTF, rhGGF2, and PDGF all up-regulated of NT-3 mRNA by and the mRNA analysis confirm that the pattern of ␤-galactosidase expression seen in sections likely regreater than 5-fold after 24 hr (Table 1) . No significant effect was observed with IGF-1, NGF (Table 1) , or the flects that of endogenous NT-3 and demonstrates that this neurotrophin is not expressed by ganglionic neuroother factors tested (data not shown). By 48 hr, NT-3 mRNA levels were up-regulated over 40-fold (normalblasts at this stage, but rather by surrounding nn cells, at least some of which are p75 ϩ .
ized to actin) in rhGGF2-or CNTF-treated cultures (Table  1) . Cell number was also dramatically increased in rhGGF2-treated cultures (not shown); however, the norGrowth Factors Enhance NT-3 mRNA Expression and NT-3-Mediated malization to actin indicates that there is a significant induction of NT-3 on a per cell basis, independent of Bioactivities in Cultured Nonneuronal Cells We next examined the regulation of NT-3 production in proliferation.
We next asked whether the increase in NT-3 mRNA nn cells isolated from ganglia by negative selection with monoclonal antibody (MAb) B2 2; see Table 5 ). This survival-enhancing effect was abol- ( Ghosh et al., 1994; Ghosh and Greenberg, 1995) NT-3 with Table 2 , top, no addition). The anti-NT-3 antibody had no effect on neuroblast survival in basal me- 1995). These biological controls indicated that the anti-NT-3 antibody does not inhibit neuroblast survival nonspecifically. These data imply that nn cells constitutively nn cells. It has been demonstrated previously that resecrete some NT-3, which is able to enhance neuroblast combinant NT-3 has at least two biological activities on survival. This conclusion is consistent with the results isolated B2 ϩ sympathetic neuroblasts: at low concentraof the RT-PCR and immunostaining analyses, in which tions (0.3-1.0 ng/ml), it can support their survival; at NT-3 mRNA was clearly detectable in untreated nn cells higher concentrations (30-50 ng/ml), it can promote mi-( Figure 3 ; see Table 1 ). totic arrest and consequent induction of TrkA (Verdi rhGGF2 , CNTF, and PDGF all enhanced the neuroblast and . We therefore asked whether these survival-promoting activity of B2 Ϫ nn cell-CM (prepared bioactivities were present in nn cell CM and if so whether from 24 hr cultures) by, on average, ‫%05ف‬ (Table 2 , they could be inhibited by function-blocking antibodies bottom). Importantly, these factors had no neuroblast to NT-3 (design illustrated in Figure 4A and 4B).
survival-promoting activity on their own (Table 2 , top). In general, rhGGF2 was most effective, consistent with We first assayed survival in cultures of isolated E14.5 The percentage of surviving neuroblasts at 48 hr is indicated. Numbers represent the mean Ϯ SEM of triplicate determinations of 100-200 cells/well, for each of three independent experiments. B2 ϩ neuroblast survival was assayed in presence of purified factors (top), or in conditioned medium (CM) from B2 Ϫ nonneuronal cells (bottom). Bottom, conditions in brackets indicate factors present during preculture to produce CM. The conditions shown at the bottom were tested in parallel with those at the top for each of three independent experiments; therefore the values at the bottom for each individual experiment should be compared with the control values (no addition) at the top for the corresponding experiment. ND, not done. a Anti-NT-3 was added at the time of assay of the CM on the isolated neuroblast cultures. Anti-NT-3 also blocked the activity of CM from PDGF-and CNTF-treated B2 Ϫ cells (data not shown). This table shows first of all that CM enhances the survival of neuroblasts; second, that anti-NT-3 blocks the effect of CM; and third, that GGF, CNTF, and PDGF increase this activity of CM but have no direct effect on neuroblasts on their own. the RT-PCR data indicating that this growth factor proof the NT-3-independent population may still be affected by environmental factors or cell-cell interactions. duced the strongest up-regulation of NT-3 mRNA in the nn cells (see Table 1 ). Importantly, all the survival-enWe next determined whether nn cell CM could induce TrkA expression in isolated neuroblasts. CM from B2 Ϫ hancing activity of these growth factor-treated CMs could be blocked by the anti-NT-3 antibody (Table 2, nn cells pretreated with rhGGF2 or PDGF up-regulated trkA mRNA expression in isolated B2 ϩ neuroblasts (Figbottom, CM [B2 Ϫ cells plus GGF] plus anti-NT-3; data not shown). These data suggest that rhGGF2, PDGF, ure 5, right; compare GGF, PDGF, with no add). This CM activity was attenuated by a function-blocking antiand CNTF all enhance neuroblast survival indirectly, by increasing the secretion of NT-3 from nn cells. The ap-NT-3 antibody ( Figure 5 , GGF plus NT-3 AB, PDGF plus NT-3 AB). The anti-NT-3 antibody did not affect the TrkAparent difference between the extent of NT-3 mRNA induction by GGF at 24 hr (about 6-fold; Table 1 ), and inducing activity of CM from cells exposed to CNTF (which has TrkA-inducing activity on its own [Verdi and the extent of the increase in survival-promoting activity with GGF-treated CM (50%) likely reflects the fact that ); this demonstrates that the antibody does not interfere nonspecifically with TrkA induction. the amount of additional NT-3 in the CM is saturating for the survival assay, as indicated by the fact that equivAs in the survival assay, rhGGF2 had no effect on TrkA expression when added directly to isolated neuroblasts alent survival was obtained with this CM as with saturating amounts of recombinant NT-3 (Table 2 ). Alterna-( Figure 5 , left, GGF). These data suggest that rhGGF2 and PDGF promote secretion of sufficient NT-3 from tively, it could reflect posttranscriptional regulation of NT-3 synthesis or secretion.
nonneuronal cells to induce trkA expression in neuroblasts. In contrast, CM from nn cells grown without these In these experiments, we consistently observed a population of neuroblasts that survived independently of growth factors had little measurable effect on TrkA expression ( Figure 5 , right, compare no add with no add NT-3. In two experiments, this basal NT-3-independent survival was approximately 50% at 24 hr and 23% at 48 plus NT-3 AB). The enhancement of neuroblast survival (Table 2) , but not TrkA expression, by untreated nn cell hr (Table 2 , top, experiments I and II, no addition; data not shown). In a third experiment, in which the neuro-CM most likely reflects the fact that higher levels of NT-3 are required to induce TrkA expression than to blast plating density was reduced by a factor of 3, basal survival was 32% at 24 hr and 15% at 48 hr (Table 2, promote survival . top, experiment III, no addition; data not shown). These data are consistent with the observation of a population Sympathetic Neuroblasts Contain mRNA of NT-3-independent sympathetic neurons in NT-3
for Various Neuregulin Isoforms mice (Ernfors et al., 1994; Fariñ as et al., 1994) . The size
The observation that growth factors such as GGF2/neuof this NT-3-independent population in the superior cerregulin and PDGF can up-regulate NT-3 mRNA expresvical ganglion in vivo is approximately 50% of the total sion and associated bioactivities in ganglionic nn cells ganglionic neuronal population. These data suggest that raised the question of whether sympathetic neuroblasts in vitro as in vivo, some embryonic sympathetic neuroblasts do not require NT-3 for survival; however, the size could be a source of such NT-3-inducing factors. It has The left of the graph (factor added directly) shows a series of controls in which factors or antibodies were added directly to isolated B2 ϩ neuroblasts. Note that NT-3 induces trkA mRNA, and that the neutralizing anti-NT-3 antibody blocks this effect. In the right of the graph, expression of TrkA was monitored in cultures of isolated B2 ϩ neuroblasts grown for 24 hr in various conditioned media from nonneuronal cultures. No add means that the conditioned medium was prepared from nn cultures grown with no added factors. Note that GGF strongly enhances the TrkA-inducing activity of nn cell CM, although by itself, GGF has no direct effect on TrkA expression in isolated neuroblasts (left side of the graph). The TrkA-inducing activity of the GGF-treated CM is strongly attenuated by anti-NT-3 antibody. A similar result is obtained with PDGF. The effect of CNTF is, as expected, not blocked by anti-NT-3, because CNTF itself has strong TrkA-inducing activity . B2 ϩ neurons indicates that conditioned medium was prepared from a coculture of B2
Ϫ nonneuronal cells and B2 ϩ neurons recombined in a 10:1 ratio (see Figure  4C ). Note that this CM has much higher TrkAinducing activity than control CM (no add) and that this activity is again attenuated by the blocking anti-NT-3 antibody. The relative levels of trkA mRNA were determined by RT-PCR and are presented as the percentage of trkA mRNA detected in PC12 cell mRNA samples run in parallel; the numbers are the mean Ϯ SEM of replicate samples. Similar results were obtained in two different experiments from separate isolations.
previously been demonstrated that a number of different CNS and PNS neuronal populations, including embryonic sympathetic neurons, make PDGF (Yeh et al., 1991) . Neuregulins have also been demonstrated to be expressed in the developing nervous system (Marchionni et al., 1993; Meyer and Birchmeier, 1994; Corfas et al., 1995) , but their expression in sympathetic neuroblasts at these stages has not specifically been examined.
We therefore assayed neuregulin mRNA production in isolated E14.5 B2 ϩ neuroblasts by RT-PCR. Using exon I-specific primers that identify mRNA encoding GGF2 (the form used in the cell culture experiments), strong signals were detected in E14.5 and E15.5 B2 ϩ cells, but were lower in E16.5 and E17.5 cells (Figure 6 ). To determine whether other neuregulin isoforms besides GGF2 were expressed in these cells, we performed RT-PCR with several different primer combinations on (Table 3) . These data, although qualitative, indithe GGF2 isoform (see Table 3 ). The values represent the mean Ϯ SEM of two independent experiments, relative to the level detected cate that various forms of neuregulins including memat E17.5 after normalization to actin. Levels of GGF2 mRNA at E19.5
brane-bound forms are synthesized by embryonic sym- sets are presented in Table 3 .
Endogenous Neuregulins Enhance Neuroblast
Survival in Cocultures enhance NT-3 production in nonneuronal cells, suggested that neuroblast-derived neuregulins might enwith Nonneuronal Cells The observations that sympathetic neuroblasts are a hance neuroblast survival in cocultures with nonneuronal cells. To test this idea, we recombined isolated potential source of neuregulins, and that neuregulins of a portion of the neuroblasts (Table 4 , anti-NT-3). Im- To determine whether the effect of B2 ϩ neuroblasts of individual neuroblasts were identified several hours in up-regulating NT-3 mRNA production in nn cells was after plating and their survival followed with time.
mediated by endogenous neuregulins, we examined Overall neuroblast survival in the cocultures at 24 hr NT-3 mRNA levels in cocultures grown with or without was 77% Ϯ 4.9% (Table 4) , much better than the 45%-the function-blocking anti-GGF2/neuregulin antibody. In 50% observed when B2 ϩ neuroblasts are cultured in control experiments, the antibody strongly attenuated isolation at the same density (see above). Inclusion of the up-regulation of NT-3 mRNA by rhGGF2, but had no anti-NT-3 antibodies in the cocultures inhibited survival effect on NT-3 mRNA up-regulation by PDGF ( Figure  7 ), demonstrating the specificity of the inhibition. Anti- We next sought to determine whether the neuroblast from duplicate rather than triplicate plates.
enhancement of NT-3 mRNA expression in nn cells was plus B2 ϩ ] plus anti-NT-3). Taken together, these data indicate that neuroblasts not only enhance the expression of NT-3 mRNA in nn cells, but also promote the secretion of NT-3-dependent bioactivities by these cells.
Finally, we asked whether the anti-rhGGF2/neuregulin antibody eliminated the enhanced secretion of survivalpromoting activity by cocultures of neuroblasts and nonneuronal cells. For this experiment, cocultures of B2 Ϫ and B2 ϩ cells were allowed to condition their medium in the presence or absence of anti-rhGGF2 antibody; the survival activity of CM from these cultures was then compared with that of CM from untreated nn cell cultures (design illustrated in Figure 4C ). In three independent experiments, pretreatment with the anti-GGF/neuregulin antibody attenuated the survival-promoting activity of the coculture-derived CM ( 
Antibody plus anti-GGF plus GGF]). Additional controls showed
Relative NT-3 mRNA levels in cultures of B2 Ϫ nonneuronal cells grown under different conditions for 24 hr were determined by RTthat the anti-GGF2/neuregulin antibody had no effect PCR (see Table 1 ) and normalized to actin mRNA levels. rhGGF2
on neuroblasts grown in basal medium, or in medium strongly up-regulates NT-3 (see also 
NT-3-independent means) (data not shown). Taken to-
NT-3 obtained with PDGF is unaffected by the anti-GGF antibody.
gether, these data indicated that neuroblast-derived NT-3 mRNA levels are also up-regulated by coculture with B2 ϩ neuneuregulin not only promotes NT-3 mRNA synthesis in roblasts, and this effect is also attenuated by the anti-GGF antibody. The data represent the average Ϯ SEM of two independent experinn cells, but also increases secretion of NT-3-dependent ments.
neuroblast survival activity from the nn cells. Discussion accompanied by an increased secretion of NT-3-dependent bioactivities. Therefore, both TrkA induction and Recent studies have established that developing rat neuroblast survival assays were performed on neurosympathetic neuroblasts undergo a switch in neuroblasts cultured in CMs derived from untreated B2 Ϫ nn trophin responsiveness DiCiccocells, 
or from cocultures of B2
Ϫ nn cells and neuroblasts Bloom et al., 1993) . At E14.5-E15.5, neuroblasts in both (design illustrated in Figure 4B and 4C). As shown in thoraco-lumbar and superior cervical ganglia express Figure 5 , conditioned medium from cocultures up-reguTrkC and respond to NT-3, but do not express TrkA. lated trkA expression in isolated B2 ϩ neuroblasts, Beginning at about E16.5, these cells begin to express whereas little effect on TrkA expression was observed TrkA and acquire NGF responsiveness as measured by with CM from nn cells alone (see Figure 5 , compare B2 ϩ 24 hr survival assays. Over the same period of time, TrkC neurons with no add). The effect of the coculture CM expression by these cells declines, and they become was attenuated by anti-NT-3 antibody (see Figure 5 , B2 ϩ relatively less sensitive to NT-3 in similar survival assays neurons plus NT-3 AB). This suggests that most or (Figure 1 ). Similar switches in neurotrophin receptor exall of the TrkA-inducing activity in CM derived from pression have been documented in developing sensory cocultures of neuroblasts and nonneuronal cells is due neurons as well (Buchman and Davies, 1993; Buj-Bello et to NT-3. al., 1994; Davies, 1994) . The observation that immature CM from cocultures also enhanced neuroblast surneurons or neuroblasts are transiently responsive to vival more effectively than did CM from untreated nn neurotrophins that differ from their ultimate targetcells ( ϩ cells, 10:1]; experiments I and III). In one of three and regulation of production of these interim trophic independent experiments, coculture and untreated nn factors. cell CM enhanced survival to a similar extent (Table 5, Here we show that NT-3 is synthesized by nn cells experiment II), but the nn cell CM had a higher level of neighboring sympathetic ganglia, and that in vitro, these survival-promoting activity to begin with than it did in cells can provide sufficient NT-3 to promote survival the other experiments (Table 5 , row 2). Importantly, all and TrkA induction in isolated neuroblasts ( Figure 8A , the survival-promoting activity of the coculture CM was top). In turn, the neuroblasts can enhance NT-3 production in the nn cells in vitro, via neuregulins and perhaps inhibited by the anti-NT-3 antibody ( Table 2 . Row 4, anti-NT-3 was added at the time of assay of the CM on the isolated neuroblast cultures. Rows 5 and 6, anti-GGF indicates that anti-GGF2 antibody was added to the cocultures at the time of plating (see Figure  4C ). Numbers in parentheses indicate the percent increase over control (no addition) observed in each CM condition. This is calculated as ([% survival in CM Ϫ % survival in no addition] Ϭ % survival in No Addition) ϫ 100. All percent increases were statistically significant (p у .034) as determined by a 2-tailed Student's t test. Note that while CM from cultures of B2 Ϫ cells alone enhances survival (by 113.6%-176%), CM from cocultures of B2 Ϫ and B2 ϩ cells is more efficacious (by 154%-193%) (except in Experiment II, in which a higher basal level of survival activity in B2 Ϫ CM was obtained). This greater efficacy is eliminated by inclusion of anti-GGF antibody during the preparation of CM, and the antibody effect is reversed by inclusion of excess recombinant human GGF. Anti-GGF antibody had no effect on CM from nonneuronal cells grown in the absence of neuroblasts (data not shown).
other factors, such as PDGF ( Figure 8A , bottom). These this cell population. However, RT-PCR measurements indicated that NT-3 transcripts are enriched at least 10-cell culture experiments thus demonstrate how a reciprocal cell-cell interaction can coordinate the developfold in isolated p75 ϩ cells, compared with levels in B2 Ϫ cells (after normalization to actin; data not shown). ment of embryonic sympathetic neuroblasts and their neighboring nonneuronal cells ( Figure 8B ). The approThese observations are consistent with the idea that p75 ϩ cells are the major if not the only source of NT-3 priate spatial and temporal expression of NT-3, neuregulins, and PDGF (Yeh et al., 1991) suggests that this interin the B2 Ϫ fraction. Taken together, these data support the idea that at least some of the NT-3-expressing nn action reconstituted in vitro may reflect normal developmental events that occur in vivo. Bidirectional cells are glia or their precursors. However, it is possible that some nonglial mesenchymal cells in the vicinity of interactions between neuroblasts and glia have also been observed in studies of cerebellar development sympathetic ganglia express NT-3 as well and contribute to the local support of neuroblast survival. (Hatten, 1987 (Hatten, , 1988 , although the molecules involved on both sides of the interaction have not been fully It is well documented that neurotrophins are produced by peripheral targets of sympathetic and sensory inidentified. Such reciprocal cell-cell interactions in the developing nervous system may provide general examnervation, where they function to support the survival of adequate numbers of neurons during the period of ples of how the development of tissues containing several distinct but functionally interrelated cell types is programmed cell death. The above mentioned data indicate that neurotrophins are also synthesized by nonneucoordinated.
ronal cells located near the cell bodies of developing sympathetic neuroblasts. This supports our earlier suggestion that NT-3 may function to provide local, interim Ganglionic Nonneuronal Cells Produce trophic support for embryonic sympathetic neuroblasts Interim Neurotrophins for Embryonic before these cells express functional NGF receptors and Sympathetic Neuroblasts gain access to target-derived NGF .
The insertion of a lacZ gene into the NT-3 locus by
This view is consistent with the idea that most or all homologous recombination has allowed us to visualize cells in the body require trophic support at multiple the pattern of NT-3 expression in tissues neighboring stages of development as well as in the adult (Raff, the developing thoraco-lumbar sympathetic ganglia.
1992). The acquisition of NGF dependence would then The domain of lacZ-expressing cells excluded the ganoccur, in part, by a substitution of a target-derived neuglionic neuroblasts and overlapped that of cells exrotrophin-NGF-for the interim neurotrophin-NT-3-pressing p75, a marker of peripheral glia and their neural provided to the neuroblast cell bodies. In addition, NGF crest precursors (Stemple and Anderson, 1992; Shah et is likely to be provided by glial cells lining the pathway al. , 1994) . Analysis of fluorescence-activated cell sorter taken by sympathetic axons to their peripheral targets (FACS)-isolated p75 ϩ cells confirmed that these cells (Johnson et al., 1988) . Such a model does not exclude express NT-3 protein and mRNA. Freshly isolated p75 ϩ the possibility that sympathetic neuroblasts are neurocells are glial fibrillary acidic protein-negative (GFAP Ϫ ), trophin independent at yet earlier stages of developbut can express GFAP when cultured in rhGGF2 plus ment; evidence for this has been provided in the chick serum (data not shown). This suggests that these cells system (Ernsberger et al., 1989a) . Evidence for a neuroare glial precursors, neural crest cells or both. Because trophin-independent stage in sensory neurogenesis has p75 ϩ cells constitute only 10%-15% of B2 Ϫ cells, we cannot say that they are the only source of NT-3 in been provided as well (Vogel and Davies, 1991) .
isoforms in these cells was not undertaken. The fact that CM from B2 ϩ neuroblasts did not induce NT-3 mRNA, whereas direct contact between these neuroblasts and the nn cells did, suggests that at least some of the NT-3-inducing activity provided by the neuroblasts may be membrane associated. In keeping with this, neuregulins are alternatively spliced to generate several membraneassociated isoforms, and we observe expression of the cytoplasmic domain-containing exon (i.e., a transmembrane form) in the neuroblasts by RT-PCR. However, it is possible that sympathetic neuroblasts also make some secreted forms of neuregulins, which did not accumulate to sufficient levels in conditioned medium from the low-density cultures, to influence NT-3 expression in nonneuronal cells.
Sympathetic neuroblasts are not the only neuronal cells that could provide a source of GGF/neuregulin for NT-3-expressing nn cells in the vicinity of the sympathetic ganglia. The preganglionic afferent nerves that grow to these ganglia contain the axons of motorneurons, which have also been shown to express various neuregulin isoforms, including ARIA, an acetylcholine receptor-inducing activity for skeletal muscle (Falls et al., 1993; Corfas et al., 1995) . These preganglionic fibers pass through the area containing lacZ ϩ NT-3-expressing cells and could therefore be an additional source of NT-3-inducing signals. Motor neurons also contain PDGF mRNA (Sasahara et al., 1991; Yeh et al., 1991) . The multiplicity of signals that can induce NT-3 in vitro makes it needed has not yet been determined (Ernfors et al., 1994; Fariñ as et al., 1994) . On the other hand, in preliminary experiments we have observed that TrkA is exRegulation of NT-3 Production in nn Cells NT-3 mRNA expression and the secretion of NT-3-pressed in the sympathetic ganglia of NT-3 Ϫ/Ϫ mice (I. F., unpublished data). This may indicate that NT-3 is dependent biologic activities in nn cells can be strongly up-regulated by environmental signals, including GGF2, only one of several functionally redundant factors that can induce TrkA expression in sympathetic neuroblasts; PDGF, and CNTF. Earlier data as well as the present results suggest that in vivo, PDGF and GGF/neuregulin indeed, we have shown that at least one other factor, CNTF, induces TrkA expression in vitro as efficiently as may be produced by sympathetic neurons neighboring the nonneuronal cells. PDGF is well known to be synthe-NT-3 . Moreover, both CNTF and NT-3 promoted mitotic arrest of sympathetic neurosized by a large number of neurons, including embryonic sympathetic neurons (Sasahara et al., 1991; Yeh et al., blasts, and mitotic inhibitors such as aphidicolin and mitomycin C were also effective inducers of TrkA (Verdi 1991) . Previous work has shown that embryonic sympathetic ganglia contain at least some forms of neuregulin and . These data suggested that the key event promoting the appearance of TrkA in sympathetic (Marchionni et al., 1993; Meyer and Birchmeier, 1994 signals or by a cell-autonomous mechanism (e.g., see
Turkey anti-NT-3 antibody was a gift from Amgen, Incorporated and Hart et al., 1989) .
has been previously demonstrated not to cross-react with other
In summary, our results demonstrate that a neuroneurotrophins (Ghosh et al., 1994; Ghosh and Greenberg, 1995) .
trophic factor that acts on immature neuroblasts is proThis antibody was used at a final concentration of 580 ng/ml, which duced by nonneuronal cells neighboring these neurowas 10-fold higher than the amount needed to block the survivalpromoting activity of 40 ng/ml NT-3. In the experiment of Figure 3 , blasts, and that its production in these cells can in turn and was preincubated with the neuroblasts prior to plating to facilitate binding to cell surface-associated forms of GGF/neuregulin.
Experimental Procedures RT-PCR
Conditions for RNA extraction, cDNA synthesis, and RT-PCR for Cell Isolation and Culture trkA and actin were as described previously (Verdi and Anderson, Sympathetic neuroblasts and associated ganglionic nonneuronal 1994). RT-PCR for NT-3 was performed with the following primers cells were isolated from E14.5 thoraco-lumbar sympathetic ganglia and amplification conditions. Forward primer, AGG TGA TGT CCA using MAb B2 for both positive and negative selection, as previously TCT TGT TTT; reverse primer, GCC TCT CCC TGC TCT GGT TC. described Verdi and Anderson, 1994 ϩ cells constitute about 7%-12% of the B2 Ϫ fraction, Growth Factors this suggests that most if not all of the NT-3 synthesized by the B2 Ϫ Recombinant NT-3 and CNTF were obtained from Amgen, Incorpofraction is synthesized by p75 ϩ cells within this fraction. However, rated and Regeneron, Incorporated, respectively, and were used at because of the larger cell numbers obtained, it was more convenient final concentrations of 25 and 2 ng/ml, respectively. rhGGF2 was to work with B2 Ϫ cells than p75 ϩ cells as a source of immunoisolated obtained from Cambridge NeuroScience, Incorporated and was nonneuronal cells.
used at concentrations that gave maximal activity in a Schwann cell For assays of TrkA expression and survival in isolated neuroblasts, DNA synthesis assay (typically 10 nM). Recombinant PDGF was typically 3,000 cells were plated per well of a 96-well plate on a from Sigma and was used at a final concentration of 20 ng/ml. poly-D-lysine/laminin substrate, in 100 l of defined, serum-free medium (L15-CO 2 containing transferrin, selenium, putrescine, progesterone, and bovine serum albumin). Determinations of neuronal Analysis of NT-3 Ϫ/Ϫ Mice survival were made by manually counting the number of neurons Mice containing the lacZ gene inserted into the NT-3 locus by homolat 24 and 48 hr and expressing the results as a percentage relative ogous recombination have been described previously (Fariñ as et to the number of cells that attached 2-3 hr after plating. Duplicate al., 1994) . Embryos were genotyped by DNA blot analysis and proor triplicate determinations were made for each experiment. The cessed by cryostat sectioning for detection of ␤-galactosidase acresults are presented as the mean Ϯ SEM.
tivity with the X-Gal reagent, followed by immunostaining for periphIn some experiments, neuroblasts and nonneuronal cells were erin (antibody from Sigma, Incorporated) or p75 (antibody Rex; reseparated following coculture according to the following proce- Weskamp and Reichardt, 1991) . dure. Cultures were treated with Hanks' balanced salt solution (HBSS; GIBCO) lacking phenol red and Mg 2ϩ , in the presence of 1 Acknowledgments mM EDTA for 1 min. Following this incubation, the medium was removed, the plates tapped gently against the hood, and the disCorrespondence should be addressed to D. J. A. We thank George lodged neuroblasts removed in 1 ml of HBSS-EDTA. This procedure Yancopoulos and Regeneron, Incorporated for their gifts of NT-3 removed >90% of neuroblasts and none of the nonneuronal cells. and CNTF; Amgen, Incorporated for NGF, FGF, NT-3, IGF, CNTF, The neurons were centrifuged and lysed in RNA extraction buffer, and the gift of anti-NT-3 neutralizing antibody; and David Kaplan while the nonneuronal cells remaining on the plate were removed for his gift of rabbit anti-NT-3 antibody. We thank Rochelle Diamond by incubation for 3 min in trypsin-EDTA (GIBCO) prewarmed to 37ЊC, for help with cell sorting, Denis Bouchard for technical assistance, spun down, and lysed.
and Nirao Shah for advice and helpful discussion. We also thank Pat White for assistance with dissections at early stages in this project. This work was supported in part by a grant from the National Preparation of nn Cell CM The costs of publication of this article were defrayed in part by after 24 hr for survival experiments. The medium was removed and mixed with 100 l of fresh medium. This medium was then used to the payment of page charges. This article must therefore by hereby marked "advertisement" in accordance with 18 USC Section 1734 culture immunoisolated E14.5 sympathetic B2 ϩ neuroblasts for 24 hr. In some experiments, similar numbers of nn cells were cocultured solely to indicate this fact. with a 10-fold lower number of B2 ϩ neuroblasts and conditioned medium taken from these cocultures after 48 hr.
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